TREATMENT OF MESOTHELIOMA

Details for Australian Patent Application No. 2003288034 (hide)

Owner NOVARTIS AG

Inventors HOHNEKER, John, Arthur

Pub. Number AU-A-2003288034

PCT Number PCT/EP2003/0125

PCT Pub. Number WO2004/043459

Priority 60/425,483 12.11.02 US

Filing date 11 November 2003

Wipo publication date 3 June 2004

International Classifications

A61K 031/4184

A61K 031/519 - ortho- or peri-condensed with heterocyclic rings

A61P 035/00 Antineoplastic agents

A61K 031/4178

A61K 031/4188

A61K 031/4196 - 1,2,4-Triazoles

A61K 031/437

A61K 031/506 - not condensed and containing further heterocyclic rings

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 60/425,483 12.11.02 US

8 July 2004 Application Open to Public Inspection

  Published as AU-A-2003288034

28 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003288035-POLYNUCLEOTIDES ENCODING AGMATINE COUMAROYLTRANSFERASE (ACT) AND USES THEREOF

2003288033-Amphoteric fluorescent whitening agents